Background: Supramolecular vesicles are a novel class of nanocarriers that have great potential in biomedicine. Methods: A multifunctional supramolecular vesicle (CAAP5G) based on the complex of CAAP5 and galactose derivative (G) assembled via host-guest interaction was constructed. Results: Using Human embryonic kidney T (293T) cells as experimental models, the cytotoxic effects of CAAP5G was investigated to 0-50 µmol/L for 24 h. Notably, the CAAP5G vesicles revealed low-toxicity to 293T cells, it was critical to designing drug nano-carriers. Simultaneously, we have evaluated doxorubicin hydrochloride (DOX)-loaded CAAP5G vesicles anticancer efficiency, where DOX-loaded CAAP5G vesicles and free DOX incubated with Human hepatocellular carcinoma cancer cell (HpeG2 cells) and 293T cells for 24 h, 48 h, 72 h. It turned out that CAAP5G vesicles encapsulated anticancer drug (DOX) could decrease DOX side-effect on 293T cells and increase DOX anticancer efficiency. More importantly, the cysteamine as an adjuvant chemotherapy drug was released from CAAP5G vesicles in HepG2 cells where a higher GSH concentration exists. The adjuvant chemotherapy efficiency was evaluated, where free DOX and DOX-loaded CAAP5G vesicles incubated with DOX-resistance HepG2 cells (HepG2-ADR cells) for 24, 48, 72 h, respectively. Conclusion: The results revealed that the DOX encapsulated by CAAP5G vesicles could enhance the cytotoxicity of DOX and provide insights for designing advanced nano-carriers toward adjuvant chemotherapies.
Introduction
Drug resistance of cancer cells and side effects to normal cells are major problems in cancer chemotherapy. [1] [2] [3] Nano-carriers (NC) are one of the most widely explored drug carriers in biomedicine with its distinctive properties. 4, 5 Especially, targeted and stimuli-responsive nano-carriers (TSNC) can target cancer cells, 6-9 achieve a rapid release in the specific tumor microenvironments, enhance cytotoxicity and reduce adverse effect via new concepts or strategies based on nanotechnology. [10] [11] [12] [13] Vesicles have been one of the most popular TSNC due to their unique cavity that have the potential to encapsulate and controllably release drugs in response to specific stimuli. [14] [15] [16] Among them, supramolecular vesicles from amphiphilic supra-molecules via host-guest complexation, especially with targeted and stimuli-responsive units, are very important in the application of biotechnology and biomedicine. [17] [18] [19] [20] Therefore, the construction of targeted and stimuli-responsive vesicles from multifunctional amphiphilic supra-molecule based on hostguest interaction between macrocyclic host molecule and guest molecule is of particular interest and importance in the progress of stimuli-responsive systems for targeted drug delivery. Pillar[n]arenes, a new class of macrocyclic host molecule, have received much attention in supramolecular chemistry. [21] [22] [23] [24] [25] [26] Due to their intrinsic symmetrical and rigid structure, accessible modification and excellent properties in host-guest chemistry, pillar[n]arenes have been widely used to construct various interesting supramolecular vesicles for TSNC. [27] [28] [29] [30] [31] For example, our group developed two types of multifunctional supramolecular vesicles, by using ferrocene or tryptophan capped pillar [5] arene, which exhibited good responsiveness and significantly enhanced the cytotoxicity of DOX.
32,33
The cystamine dihydrochloride (CA), an important pharmaceutical intermediate that contained a disulfide bond (sensitive to GSH) and amino groups (sensitive to pH), was investigated. [34] [35] [36] Most importantly, CA can produce the drug cysteamine in the presence of GSH for adjuvant chemotherapy. 37 Previous studies showed that the cysteamine not only inhibited the formation of gastric 38 and mammary tumors 39 that were induced chemically or after irradiation, 40, 41 and also enhanced the cytotoxicity of DOX. 42 To the best of our knowledge, CA modified pillararene for constructing a dual-responsive amphiphilic host molecule have not yet been reported. We hypothesized that synthesis of CA capping pillararene would not only lead to a GSH-pH dual responsive amphiphilic host molecule, but also the cysteamine produced by the CA could enhance the cytotoxicity of DOX for adjuvant chemotherapy. In this study, a CA-capped pillar [5] arene (CAAP5) amphiphilic host molecule was first synthesized, and thereafter the multifunctional supramolecular vesicles (CAAP5G) constructed from CAAP5 and a galactose derivative guest molecule (G) based on host-guest interaction for targeted drug nanocarriers (Scheme 1), where the galactose residue on one end of G can act as the targeting ligand to asialoglycoprotein receptor (ASGP-R) overexpressing HepG2 cells via carbohydrate-protein interactions. 43 
Material and methods

Instrumentation and materials
All chemical reagents were of analytical reagent grade and used without further purification unless specified. Doxorubicin hydrochloride was purchased from Sangon Biotech. 
Methods
The preparation and characterization of the vesicles 2.46 mg (0.5 µmol) of CAAP5 was dissolved in H 2 O (0.5 mL) and stirred for 5 min. The solution was mixed 0.5 mL G (1 mM). The final mixture was ultrasonicated for 30 min, then left to stand for 6 h to obtain the vesicles of CAAP5G, which were characterized by SEM, DLS, and TEM, respectively.
DOX loading and release of CAAP5G vesicles
2.46 mg (0.5 µmol) of CAAP5 was dissolved in H 2 O (0.5 mL) and stirred for 5 min. To the solution were mixed 0.5 mL G (1 µmol) and 0.58 mg DOX (1 µmol). The mixture was ultrasonicated for 30 min and left to stand for 6 h, then subjected to dialysis (molecular weight cutoff 8,000-14,000) in distilled water. DOX-loaded vesicles were obtained when no DOX detected in the water outside the dialysis tube.
GSH (10 mM). 1 mL of DOX-loaded vesicles in a dialysis bag was added into 10 mL of corresponding release medium at room temperature. Within specified time intervals, 0.1 mL of the release medium was taken out for measuring the DOX released with an Epoch microplate spectrophotometer (Biotek).
Cell culture and cell viability
HepG2 cells and HepG2-ADR cells were cultured in RPMI 1640 containing 1% penicillin-streptomycin, 10% FBS, in a humidified atmosphere (5% CO 2 ) at 37°C. 293T cells were cultured in DMEM medium containing 1% penicillin-streptomycin, 10% FBS, in a humidified atmosphere (5% CO 2 ) at 37°C. The relative cytotoxicity of unloaded vesicles, DOX and DOX-loaded vesicles were evaluated in vitro by MTT assay, respectively. MTT assay procedures refer to our previous work. 44 
Results and discussion
To acquire CAAP5, azido-pillar [5] arene H5 and alkynyl cystamine derivative H4 were synthesized according to a published procedure, respectively. 45, 46 The CAAP5 can be synthesized through Cu-catalyzed azido-alkynyl click reaction. The synthetic details and characterization of CAAP5 and G can be found in the Supporting Information (Schemes S1-S3, Figures S1-S11) . (H 1-3 ) of G were observed due to the shielding effect of the electron-rich cavities of CAAP5 toward G (see in Figure S12 ). This result was consistent with that published, 21, 32, 33 demonstrating the pyridine moiety of G has been successfully included into the hydrophobic cavity of CAAP5.
To construct the targeting dual-responsive supramolecular vesicles (CAAP5G) based on the CAAP5 and G host-guest interaction, an aqueous solution of CAAP5 and G was sonicated for 30 min. We observed a clear Tyndall effect ( Figure 1A right) , indicating the existence of abundant nanoparticles, which were further identified by scanning electron microscopy SEM ( Figure 1B) . TEM image demonstrated the cavity of the vesicles, which was used to loading-drug ( Figure 1C ). Further analysis with DLS showed that the average diameter of the vesicles was 158 nm ( Figure 1D ). The critical aggregation concentration (CAC) was found to be 22 µM by the water surface tension method ( Figure S14 ).
In the following study, DOX was selected as a model drug to investigate the drug release behavior and encapsulation efficiency of the supramolecular vesicles. As showed in Figure 1A (left), a clear Tyndall effect was observed with DOX-loaded CAAP5G aqueous solution. DLS showed that the average diameter of the DOX-loaded CAAP5G vesicles was 203 nm ( Figure S13 ), which were further identified by SEM (Figure 2A ). The CAAP5G encapsulation efficiency was calculated 41 wt% by UVvis spectroscopy. Subsequently, the DOX-loaded cells were incubated with DOX-loaded CAAP5G vesicles and free DOX at 5 µM for 4 h, respectively, where the efficiency of cellular uptake was analyzed by flow cytometry. HepG2 cells pre-cultured with lactose (2 mg/mL) for 4 h, were used to culture with DOX-loaded CAAP5G vesicles for comparison. As showed in Figure 3B , the fluorescence intensity of HepG2 cells cultured with DOX-loaded CAAP5G vesicles (blue curve) was higher than that of DOX-loaded CAAP5G with lactose pre-incubation (green curve), indicating a higher uptake of DOX-loaded CAAP5G vesicles. The results imply that CAAP5G displays hepatoma-targeting ability. In addition, the cell toxicity of unloaded vesicles to 293T cells are evaluated by the MTT cell survival assay. As indicated in Figure S15 (ESI †), the relative cell viability of 293T cells cultured with unloaded vesicles was over 82% in the concentrations of 50 μM CAAP5G after 24 h, showing that the vesicles had low cell toxicity to 293T cells, which was essential for the design of drug nano-carriers. The anticancer efficency of DOX-loaded CAAP5G vesicles was evaluated using MTT cell survival assay, where HpeG2 cells and 293T cells were incubated with free DOX and DOX-loaded CAAP5G vesicles for 24, 48, and 72 h, respectively. As indicated in Figure 4A , in all three tested periods, the relative viabilities of HepG2 cells after cultured with DOX-loaded CAAP5G vesicles were visibly lower than those with free DOX. By comparison, 293T cells showed higher relative viabilities than those with free DOX ( Figure 4A ). The results indicated that the encapsulation of DOX by CAAP5G vesicles could enhance the drug anticancer efficiency for HepG2 cells while effectively reduce the side effects to 293T cells.
In the presence of GSH, CAAP5G vesicles can produce the cysteamine, an adjuvant chemotherapy drug, that enhances the cytotoxicity of DOX. 42 To study the adjuvant chemotherapy efficiency of CAAP5G vesicles, HepG2-ADR cells were cultured with free DOX and DOX-loaded CAAP5G vesicles for 24, 48, and 72 h, respectively ( Figure 5 ). The results showed that the relative viabilities of HepG2-ADR cells after incubation with DOX-loaded CAAP5G vesicles at all three tested time periods were visibly lower than those with free DOX. It indicated DOXloaded CAAP5G vesicles could enhance anticancer efficiency of HepG2-ADR cells comparison with free DOX, suggesting CAAP5G as a multifunctional supramolecular vesicle can be used in adjuvant chemotherapy.
Conclusion
In conclusion, novel multifunctional supramolecular vesicles (CAAP5G) based on the host-guest complexation of CAAP5 and G have been successfully constructed and the good drug-loading capability was demonstrated by drug loading experiments. Furthermore, DOX-loaded CAAP5G not only exhibited excellent dual stimuli responsiveness and rapid release of DOX in cancer cells but also possesses targeting ability to ASGP-R overexpressing HepG2 cells. Most notably, the vesicles under high concentration of GSH would release cysteamine, which could enhance the anticancer efficiency of DOX and reduce the drug resistance of cancer cells. This work provides a new idea for rational design in the construction of targeted and stimuli-responsive nanocarriers for drug delivery, which have great applications for adjuvant chemotherapy. Times (h) Figure 5 Comparison of DOX-loaded CAAP5G vesicles and DOX on viabilities of HepG2-ADR cells at different time periods; the concentration of DOX was 5 µM. Statistically significant differences were observed (*p<0.05).
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